Related Experiment Video
Updated: Apr 30, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Usability of a Reminder App that May Help to Reduce Radiotherapy-related Skin Toxicity in Patients With Breast Cancer
Dirk Rades1,2, Liesa Dziggel2, Carlos A Narvaez-Wolf2
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; dirk.rades@uksh.de.
Background/Aim:
Patients irradiated for breast cancer may experience acute skin toxicity. To reduce this risk, a mobile application was created which reminds patients to carry out skin care. Before using this app in patients, a pre-study evaluating its usability in healthy volunteers was required.
Patients And Methods:
In this prospective study, 30 healthy volunteers from Germany and Denmark were asked to test the app and complete a questionnaire including ten statements ("yes or "no") in three sections.
Results:
Satisfaction rates (statements affirmed with "yes") were 66.7% (18/27 participants) and 78.6% (22/28) in the section "download and installation", and 100% (29/29) and 96.7% (29/30) in the section "navigation". In the section "content/functions", the six statements were addressed by 28-30 participants; satisfaction rates were 86.7% to 100% (median 96.5%). Dichotomous responses were supplemented by individual comments.
Conclusion:
This study revealed that the reminder app needed improvement before tested in patients and demonstrated the importance of a pre-study in healthy volunteers.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Radiation: Applications
The average...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

